U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA ® (ustekinumab-stba), a biosimilar to STELARA ® (ustekinumab), in a 45mg/0.5mL solution in a single-dose vial for ...

The global cleanroom technology in healthcare market revenue was around US$ 5.2 billion in 2022 and is estimated to reach US$ 8.6 billion by 2032, growing at a compound annual growth rate (CAGR) of ...

At least two people died and a number were swept away after a bridge over the Indrayani river in the western Indian city of ...

Despite a strong performance at the Oceania Women’s Championship and successfully defending their title, Fijiana XV head ...